Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1983-12-17
|
pubmed:abstractText |
Twenty-two patients with acute lymphoblastic leukemia in second or subsequent remission and 26 with acute lymphoblastic leukemia in relapse were given cyclophosphamide (60 mg/kg on each of 2 days), total body irradiation (920 rad), and marrow transplants from HLA-identical siblings. With a minimum follow-up of more than 5 yr, an actuarial analysis shows a survival and apparent cure of 27% of the patients transplanted in remission and 15% of the patients transplanted in relapse.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1139-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6354306-Bone Marrow Transplantation,
pubmed-meshheading:6354306-Combined Modality Therapy,
pubmed-meshheading:6354306-Cyclophosphamide,
pubmed-meshheading:6354306-Follow-Up Studies,
pubmed-meshheading:6354306-Humans,
pubmed-meshheading:6354306-Leukemia, Lymphoid,
pubmed-meshheading:6354306-Prognosis,
pubmed-meshheading:6354306-Whole-Body Irradiation
|
pubmed:year |
1983
|
pubmed:articleTitle |
Marrow transplantation for patients with acute lymphoblastic leukemia: a long-term follow-up.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|